By NEIL UNMACK
A friendly takeover deal for Allergan’s generic drugs unit is far easier than the hostile bid that Teva was pursuing for Mylan.
Published: July 28, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1JL9TFy
from WordPress http://ift.tt/1gZY9bd
via Hadi Aboukhater
No comments:
Post a Comment